Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized multiple-dose TP-102 study in diabetic foot ulcers with or without infection
MOH_2021-02-01_009713Phase 2Completed
- Sponsor
- TechnoPhage
- Start
- Oct 2020
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TP-102 in diabetic foot ulcer (DFU) (4 arms), sponsored by TechnoPhage. Started Oct 2020; status: completed.
02
Drugs
TP-102
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on MOH_2021-02-01_009713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-02-01_009713.